As summer approaches, pharmacy staff may begin to field more questions about how patients can manage their health and their medications while they travel, especially during extended travel abroad.

Sonya Collins

Chronic pain is common and debilitating, and its treatment continues to present challenges to the medical community.

Sonya Collins

There is an expanding variety of home testing and monitoring kits available for patients interested in preventative care, detecting the presence or absence of a medical or physiologic condition, and monitoring therapy or results of a wellness routine.

A federal judge in Ohio who oversees the National Prescription Opiate Litigation (NPOL) has recently issued a ruling with significant implications for pharmacists and pharmacies.

David B. Brushwood, BSPharm, JD

Mental health disorders are common, complex to diagnose and treat, and costly to manage. They are also associated with a high risk of morbidity and mortality. Common disorders such as depression and anxiety are among the leading causes of disease burden globally. WHO reports that anxiety disorders affect over 260 million people.

Adrijana Kekic, PharmD, CTLC

Topical analgesics are often used to relieve pain associated with aches and pains in muscles and joints, such as backaches, arthritis, strains, bruises, and sprains.

Mary Warner

The American Society of Health-System Pharmacists (ASHP) and ASHP Foundation released the 11th edition of the Pharmacy Forecast report, which provides an insightful perspective on the factors that can affect patient care, population health, and the pharmacy profession.

Aneesh Asokan, PharmD, MBA

An article published on January 21, 2023, in AJHP reveals some welcome findings: When pharmacists are involved in antibiotic selection, hospitals can potentially save money and patients are less likely to be prescribed undesirable second-line therapies.

Olivia C. Welter, PharmD

A Minute With... 

Samantha Freiter, APhA–ASP Chapter President
and 2024 PharmD candidate, University of Pittsburgh
School of Pharmacy

Member since 2020

FDA issued an EUA on February 24, 2023, for the first at-home OTC diagnostic test that can differentiate and detect influenza A and B and the SARS-CoV-2 virus.